Vaccine Preventable Diseases in Australia, 2005 to 2007


Page last updated: 24 December 2010

7vPCV 7-valent pneumococcal conjugate vaccine

23vPPV 23-valent pneumococcal polysaccharide vaccine

ABS Australian Bureau of Statistics

ACIP Advisory Committee on Immunization Practices (USA)

ACT Australian Capital Territory

ADT Adult diphtheria-tetanus

AFP Acute flaccid paralysis

AIHW Australian Institute of Health and Welfare

APSU Australian Paediatric Surveillance Unit

ASVS Australian Standard Vaccination Schedule

aVDPV Ambiguous vaccine-derived poliovirus

CRS Congenital rubella syndrome

cVDPV Circulating vaccine-derived poliovirus

DT Diphtheria-tetanus (child formulation)

dT Adolescent/adult diphtheria-tetanus

DTP Diphtheria-tetanus-pertussis (child formulation)

DTPa Diphtheria-tetanus-pertussis (acellular) (child formulation)

dTpa Adolescent/adult diphtheria-tetanus-pertussis (acellular)

DTPw Diphtheria-tetanus-pertussis (whole cell) (child formulation)

FAG Finance assistance grant

HAV Hepatitis A virus

HbOC Haemophilus influenzae type b polysaccharide conjugated to non-toxic diphtheria CRM197 protein

HBsAg Hepatitis B surface antigen

HBV Hepatitis B virus

HFG Hospital funding grant

Hib Haemophilus influenzae type b

HPV Human papillomavirus

ICD International Classification of Diseases

ICD-9 International Classification of Diseases, 9th Revision

ICD-9-CM International Classification of Diseases, 9th Revision, Clinical Modification

ICD-10 International Classification of Diseases, 10th Revision

ICD-10-AM International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Australian Modification

IgG Immunoglobulin G

IgM Immunoglobulin M

IDU Injecting drug users

IPD Invasive pneumococcal disease

IPV Inactivated poliovirus vaccine

iVDPV Immunodeficiency-associated vaccine-derived poliovirus

LOS Length of stay (in hospital)

MenCCV Meningococcal C conjugate vaccine

MMR Measles-mumps-rubella

MSM Men who have sex with men

NCCH National Centre for Classification in Health

NCIRS National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases

NHMRC National Health and Medical Research Council

NIP National Immunisation Program

NIPII National Indigenous Pneumococcal and Influenza Immunisation (Program)

NNDSS National Notifiable Diseases Surveillance System

n.p. Not published

NQFMP National Q Fever Management Program

NSW New South Wales

NT Northern Territory

OPV Oral poliovirus vaccine

PBS Pharmaceutical Benefits Scheme

PCR Polymerase chain reaction

PHOFA Public Health Outcome Funding Agreement

PRP-D Haemophilus influenzae type b polysaccharide conjugated to diphtheria toxoid

PRP-OMP Haemophilus influenzae type b polysaccharide conjugated to the outer membrane protein of Neisseria meningitidis vaccine

PRP-T Haemophilus influenzae type b polysaccharide conjugated to tetanus toxoid

Qld Queensland

R Effective reproductive number

RSV Respiratory syncytial virus

SA South Australia

SSPE Subacute sclerosing panencephalitis

Tas Tasmania

VAPP Vaccine-associated paralytic poliomyelitis

VDPV Vaccine-derived poliovirus

aVDPV Ambiguous vaccine-derived poliovirus

cVDPV Circulating vaccine-derived poliovirus

iVDPV Immunodeficiency-associated vaccine-derived poliovirus

Vic Victoria

VPD Vaccine preventable disease

VZV Varicella-zoster virus

WA Western Australia

WHO World Health Organization

Document download

This publication is available as a downloadable document.

Vaccine Preventable Diseases in Australia, 2005 to 2007(PDF 1217 KB)